Companies: 10,795·Total market cap: $144.5T
Insight Molecular Diagnostics Inc.

Insight Molecular Diagnostics Inc.

IMDXNASDAQHealthcare● Active
$5.72
+$0.48(+9.16%)
Market Cap$153533168
P/E Ratio
52W High$8.51
52W Low$2.33
Overview

Insight Molecular Diagnostics Inc.(IMDX)股价预测与分析师目标价

华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。

imdx · 股价预测 · 11 位分析师(近3月)· FMP · 更新于 2026年6月8日

分析师评级与共识

基于过去 3 个月内 11 位华尔街分析师

SellBuy

Buy

11 位分析师

共识

评级分布

Strong Buy
0
Buy
7
Hold
4
Sell
0
Strong Sell
0
合计: 11 · 买入占比: 63.6%

12 个月目标价

High

$12.00

Consensus

$12.00

+109.8% upside

Low

$12.00

Median: $12 · Last Close: $5.72

Insight Molecular Diagnostics Inc.(IMDX)的分析师共识为 Buy,基于过去 3 个月内 11 位华尔街分析师的评级。IMDX 的 12 个月平均目标价为 $12.00,相对当前价 $5.72 代表 +109.8% 的潜在上行空间。

12 个月目标价预测

历史收盘价 + 分析师 12 个月目标价预测区间

分析师目标价覆盖不足,无法为该股票生成预测图表。

短期股价预测

算法生成 · 每日更新

DatePredicted PriceChange
2026-06-10$5.680.62%

1-day model range: $5.58–$5.79. Peak: $5.79 (-0.62%).

长期股价预测

年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$4-26.5%
2028$4-36.2%
2029$3-40.4%
2030$3-42.4%
2031-43.4%
Confidence:Medium

基于技术分析的股价预测

14 项技术面信号(SMA×6 + EMA×6 + RSI + MACD)· EEAT 方法论透明

Market Sentiment

NEUTRAL

Based on 14 technical indicators

50%7%43%
7Buy
1Neutral
6Sell
RSI (14)44.2Neutral
MACDBULLISH

Refreshes daily from EOD close

Moving Averages · IMDX · Jun 9, 2026

Simple Moving Average (SMA)
MA 5$5.90SELL
MA 10$6.12SELL
MA 20$5.96SELL
MA 50$4.65BUY
MA 100$5.18BUY
MA 200$5.10BUY
Current $IMDX · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$5.85SELL
EMA 10$5.94SELL
EMA 20$5.77SELL
EMA 50$5.27BUY
EMA 100$5.13BUY
EMA 200$4.87BUY
Current $IMDX · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

最新分析师评级与调整

Filter:
Lake Street2026-02-17
Maintains
BuyBuy
Needham2025-11-11
Maintains
BuyBuy
Needham2025-08-18
Maintains
BuyBuy
Lake Street2025-05-21
Maintains
BuyBuy
Needham2025-05-13
Maintains
BuyBuy
Needham2025-04-08
Maintains
BuyBuy
Stephens & Co.2025-03-26
Maintains
Equal WeightEqual Weight
Needham2025-03-25
Maintains
BuyBuy
Stephens & Co.2025-03-25
Maintains
Equal WeightEqual Weight
Benchmark2023-08-23
Maintains
Speculative BuySpeculative Buy

Wall Street analysts have recently issued updated ratings on Insight Molecular Diagnostics Inc. (IMDX) stock. Of the recent 45 rating actions, 1 were upgrades and 6 were downgrades. 11 analysts currently cover IMDX.

分析师推荐趋势

Buy ratings11
Hold ratings202
Sell ratings00

IMDX analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.

财务预测:EPS 与营收一致预期

Revenue This Year

$1M

↓ 76.7% YoY

Revenue Next Year

$3M

↑ 545.0% YoY

EPS This Year

$-2.74

EPS Next Year

$-1.15

↓ 58.2% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast IMDX EPS of $-2.74 for the current fiscal year, based on estimates from 1 analysts. The IMDX revenue forecast is $1M for the current year. These are analyst consensus estimates via FMP / S&P Global.

关于预测与目标价

IMDX 股价预测由两类独立数据源支撑:来自 11 位华尔街分析师(S&P Global / FMP)的共识评级,以及基于历史日终价计算的技术分析。IMDX 的共识目标价为 $12.00(+109.8% 上行空间),分析师共识为 Buy。

IMDX 的短期预测(明日)为 $5.68(-0.62%)。 IMDX 对 2027 年的股价预测均值为 $4。 IMDX 对 2030 年的预测区间为 $3–$4。

Insight Molecular Diagnostics Inc. 在 NASDAQ 上市,代码 IMDX。IMDX 在 2027 年的整体展望偏积极,在覆盖分析师中约 64% 对应 Buy 共识。

常见问题答案综合分析师目标价、一致预期及页面展示的模型结果。

常见问题

IMDX 预测 · 8 个问题

根据 11 位华尔街分析师,IMDX 的 12 个月平均目标价为 $12.00,最高 $12.00、最低 $12.00。若有图表,中位目标价可在上方查看。相对当前价 $5.72,隐含约 +109.8% 的上行空间。

IMDX 目标价IMDX 分析师目标价IMDX 12个月目标价目标价 IMDX

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.